SEC Tracker
Get the app

Possible new IMDX shares

IMDXDilution

Known so far: no new shares from the prospectus covers read · shelf room about $10.8M · not yet read: warrants, converts, options, ATM.

Shelf room

  • Room today about $10.8M
  • One third of float $10.8M ($32.4M float, Jun 30, 2025)
  • Sold off it, 12 months nothing
How this is worked out

Shelf room about $10.8M on the S-3 of Oct 18, 2024: the baby-shelf rule (public float under $75M) caps sales at one third of the $32.4M public float stated as of Jun 30, 2025, $10.8M, nothing sold off it in the last 12 months. Sources: S-3/A Oct 18, 2024, effective Oct 21, 2024 · public float, as of Jun 30, 2025.

What could become new Insight Molecular Diagnostics (IMDX) shares, from its 10-Q, 10-K, S-1 or 424B filings.

Read so far: the cover share count (32.7M shares, +14% from 28.6M on Aug 4, 2025). Not read yet: warrants, convertible notes, options and RSUs and an ATM program. Read them on EDGAR: the latest 10-Q · S-1 registration filings.

Shares outstanding

32.7M

Nov 2024 to Aug 2026: from 16.8M to 32.7M.

From the share count on the cover of each 10-Q and 10-K, dated as each cover states.